Nektar Therapeutics $NKTR announced its equity offering of 13 million shares of common stock at $13.50. Underwriters will have the option to purchase an additional 1.95 million shares. The net proceeds from the offering will fund R&D activities, working capital requirements and other general corporate purposes. The stock closed at $14.08 on Wednesday.